iRFP is a real time marker for transformation based assays in high content screening.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24887316.
- Also identified by DOI 10.1371/journal.pone.0098399 and PMC identifier 4041769.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Anchorage independent growth is one of the hallmarks of oncogenic transformation. Here we show that infrared fluorescent protein (iRFP) based assays allow accurate and unbiased determination of colony formation and anchorage independent growth over time. This protocol is particularly compatible with high throughput systems, in contrast to traditional methods which are often labor-intensive, subjective to bias and do not allow further analysis using the same cells. Transformation in a single layer soft agar assay could be documented as early as 2 to 3 days in a 96 well format, which can be easily combined with standard transfection, infection and compound screening setups to allow for high throughput screening to identify therapeutic targets.
Medical subject headings
- Biomarkers, Tumor
- Cell Transformation, Neoplastic
- Luminescent Proteins